185 related articles for article (PubMed ID: 9804698)
1. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
[TBL] [Abstract][Full Text] [Related]
2. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
[TBL] [Abstract][Full Text] [Related]
3. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Oct; 41(21):4053-61. PubMed ID: 9767642
[TBL] [Abstract][Full Text] [Related]
4. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
[TBL] [Abstract][Full Text] [Related]
5. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
[TBL] [Abstract][Full Text] [Related]
6. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
[TBL] [Abstract][Full Text] [Related]
7. Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks.
Sawada Y; Kayakiri H; Abe Y; Mizutani T; Inamura N; Asano M; Hatori C; Aramori I; Oku T; Tanaka H
J Med Chem; 2004 May; 47(11):2853-63. PubMed ID: 15139763
[TBL] [Abstract][Full Text] [Related]
8. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
9. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
11. A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference.
Sawada Y; Kayakiri H; Abe Y; Imai K; Mizutani T; Inamura N; Asano M; Aramori I; Hatori C; Katayama A; Oku T; Tanaka H
J Med Chem; 2004 Mar; 47(7):1617-30. PubMed ID: 15027853
[TBL] [Abstract][Full Text] [Related]
12. A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile.
Sawada Y; Kayakiri H; Abe Y; Mizutani T; Inamura N; Asano M; Aramori I; Hatori C; Oku T; Tanaka H
J Med Chem; 2004 May; 47(10):2667-77. PubMed ID: 15115408
[TBL] [Abstract][Full Text] [Related]
13. [Discovery of highly potent and orally active non-peptide bradykinin B2 receptor antagonists].
Kayakiri H
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):996-1000. PubMed ID: 10771664
[No Abstract] [Full Text] [Related]
14. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 1. Synthesis and SAR of alpha,alpha-dimethylglycine sulfonamides.
Fattori D; Rossi C; Fincham CI; Berettoni M; Calvani F; Catrambone F; Felicetti P; Gensini M; Terracciano R; Altamura M; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
J Med Chem; 2006 Jun; 49(12):3602-13. PubMed ID: 16759102
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
[TBL] [Abstract][Full Text] [Related]
16. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Griesbacher T; Legat FJ
Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
[TBL] [Abstract][Full Text] [Related]
17. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
Majima M; Kawashima N; Hiroshi I; Katori M
Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
[TBL] [Abstract][Full Text] [Related]
18. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.
Fattori D; Rossi C; Fincham CI; Caciagli V; Catrambone F; D'Andrea P; Felicetti P; Gensini M; Marastoni E; Nannicini R; Paris M; Terracciano R; Bressan A; Giuliani S; Maggi CA; Meini S; Valenti C; Quartara L
J Med Chem; 2007 Feb; 50(3):550-65. PubMed ID: 17266207
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
Robert C; Pruneau D; Paquet JL
Br J Pharmacol; 2002 Jan; 135(2):462-8. PubMed ID: 11815382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
